Results 201 to 210 of about 12,242 (218)

Chikungunya virus (CHIKV): What can be expected after the acute phase?

Reumatología Clínica (English Edition), 2016
Vianna J, Khoury, Pablo R, Camilo
openaire   +2 more sources

Chikungunya Virus (CHIKV) Pathogenesis: From Acute Fever to Chronic Arthritis—Immune Mechanisms and Therapeutic Implications

Current Topics in Medicinal Chemistry
Chikungunya Virus (CHIKV) is an arthropod-borne alphavirus that represents a substantial worldwide health burden. A percentage of patients go on to suffer from Chronic Chikungunya Arthritis (CCA) that lasts for months, or even years, and causes disability.
Dongbing Li, Guizhen Lyu
openaire   +2 more sources

EPH160 Burden of Illness (BOI) and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)

Value in Health, 2022
K Bakker, H Hofstra, A Dijkstra, G Gurgel, B Wolters   +4 more
openaire   +1 more source

Chikungunya Virus (CHIKV) Serology Correlation with PCR at a Commercial�Laboratory Since Emergence of CHIKV in the Americas

2014
Batterman, Holly, Prince, Harry, Seaton, Brent, Schwab, Dale, Pesano, Rick   +4 more
openaire   +1 more source

EPH15 Transmission Dynamics and Vaccination Strategies for Chikungunya Virus (CHIKV): An Outbreak Simulation Study in Rome, Italy

Value in Health, 2023
G. Tiozzo, B. Sloof, H. Hofstra, G.T. Vondeling, A. de Roo   +4 more
openaire   +1 more source

Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine

Journal of Infectious Diseases, 2020
Barbara Schnierle, Sally A Baylis, Lia Laura Lewis-Ximenez   +2 more
exaly  

Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis

Virologica Sinica, 2019
Se Kim, Jihyun Yang, Haryoung Poo
exaly  

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

Vaccine, 2008
Niranjan Sardesai, Kar Muthumani, P Vijayachari   +2 more
exaly  

Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model

Vaccine, 2013
Scott Weaver, Jorge Osório, Marulasiddappa Suresh   +2 more
exaly  

Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery

Antimicrobial Agents and Chemotherapy, 2020
Rana Abdelnabi, Verena Battisti, Johan Neyts   +2 more
exaly